• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症干细胞基因表达的表观遗传调控。

Epigenetic regulation of cancer stem cell gene expression.

作者信息

Bapat Sharmila A

机构信息

National Centre for Cell Science, NCCS Complex, Pune University Campus, Ganeshkhind, Pune, 411 007, India,

出版信息

Subcell Biochem. 2013;61:419-34. doi: 10.1007/978-94-007-4525-4_18.

DOI:10.1007/978-94-007-4525-4_18
PMID:23150261
Abstract

The concept of cancer as a stem cell disease has slowly gained ground over the last decade. A 'stem-like' state essentially necessitates that some cells in the developing tumor express the properties of remaining quiescent, self-renewing and regenerating tumors through establishment of aberrant cellular hierarchies. Alternatively, such capacities may also be reacquired through a de-differentiation process. The abnormal cellular differentiation patterns involved during either process during carcinogenesis are likely to be driven through a combination of genetic events and epigenetic regulation. The role(s) of the latter is increasingly being appreciated in acquiring the requisite genomic specificity and flexibility required for phenotypic plasticity, specifically in a context wherein genome sequences are not altered for differentiation to ensue. In this chapter, the recent advances in elucidating epigenetic mechanisms that govern the self-renewal, differentiation and regenerative potentials of cancer stem cells will be presented.

摘要

在过去十年中,癌症作为一种干细胞疾病的概念逐渐得到认可。一种“干细胞样”状态本质上要求发育中的肿瘤中的一些细胞通过建立异常的细胞层次结构来表现出保持静止、自我更新和再生肿瘤的特性。或者,这些能力也可以通过去分化过程重新获得。致癌过程中任一过程所涉及的异常细胞分化模式可能是由遗传事件和表观遗传调控共同驱动的。后者在获得表型可塑性所需的必要基因组特异性和灵活性方面的作用越来越受到重视,特别是在基因组序列不发生改变就能实现分化的情况下。在本章中,将介绍在阐明调控癌症干细胞自我更新、分化和再生潜能的表观遗传机制方面的最新进展。

相似文献

1
Epigenetic regulation of cancer stem cell gene expression.癌症干细胞基因表达的表观遗传调控。
Subcell Biochem. 2013;61:419-34. doi: 10.1007/978-94-007-4525-4_18.
2
Cancer: an epigenetic landscape.癌症:一种表观遗传景观。
Subcell Biochem. 2013;61:399-417. doi: 10.1007/978-94-007-4525-4_17.
3
Epigenetic codes in stem cells and cancer stem cells.干细胞和癌症干细胞中的表观遗传密码。
Adv Genet. 2010;70:177-99. doi: 10.1016/B978-0-12-380866-0.60007-1.
4
Epigenetic changes in cancer.癌症中的表观遗传变化。
Annu Rev Pathol. 2009;4:229-49. doi: 10.1146/annurev.pathol.3.121806.151442.
5
Stem cell plasticity in development and cancer: epigenetic origin of cancer stem cells.发育与癌症中的干细胞可塑性:癌症干细胞的表观遗传学起源
Subcell Biochem. 2013;61:545-65. doi: 10.1007/978-94-007-4525-4_24.
6
Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.表观遗传药物作为癌症治疗中的多效性药物:生物分子方面及临床应用
J Cell Physiol. 2007 Aug;212(2):330-44. doi: 10.1002/jcp.21066.
7
DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.癌症患者的DNA甲基化和组蛋白修饰:潜在的预后和治疗靶点。
Methods Mol Biol. 2007;361:25-62. doi: 10.1385/1-59745-208-4:25.
8
Oncogenes and tumor suppressor genes as paradigms in oncogenesis.作为肿瘤发生范例的癌基因和肿瘤抑制基因。
J BUON. 2007 Sep;12 Suppl 1:S9-12.
9
Histone acetylation and chromatin signature in stem cell identity and cancer.干细胞特性与癌症中的组蛋白乙酰化和染色质特征
Mutat Res. 2008 Jan 1;637(1-2):1-15. doi: 10.1016/j.mrfmmm.2007.07.012. Epub 2007 Aug 1.
10
Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.重叠基因可能控制小鼠体细胞重编程为诱导多能干细胞(iPSC)以及乳腺癌干细胞的过程。
In Silico Biol. 2010;10(5-6):207-21. doi: 10.3233/ISB-2010-0437.

引用本文的文献

1
Panobinostat, a histone deacetylase inhibitor, rescues the angiogenic potential of endothelial colony-forming cells in moyamoya disease.帕比司他,一种组蛋白去乙酰化酶抑制剂,可挽救烟雾病中内皮祖细胞的血管生成潜能。
Childs Nerv Syst. 2019 May;35(5):823-831. doi: 10.1007/s00381-019-04099-y. Epub 2019 Feb 27.
2
Novel molecular insights and new therapeutic strategies in osteosarcoma.骨肉瘤的新型分子见解与新治疗策略
Cancer Cell Int. 2018 Oct 16;18:158. doi: 10.1186/s12935-018-0654-4. eCollection 2018.
3
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells.
转录组而非基因组的变异性赋予了乳腺癌干细胞的表型。
Cancer Commun (Lond). 2018 Sep 19;38(1):56. doi: 10.1186/s40880-018-0326-8.
4
The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis.JAZF1-SUZ12融合蛋白在人子宫内膜间质肿瘤发生过程中破坏PRC2复合物并损害染色质抑制作用。
Oncotarget. 2017 Jan 17;8(3):4062-4078. doi: 10.18632/oncotarget.13270.